speb/financial-data huggingface dataset:
MDM.V income_statement (quarterly, 2026-02-28) — Net Income From Continuing And Discontinued Operation: -86841.00
MDM.V income_statement (annual, 2026-02-28) — Net Income From Continuing Operation Net Minority Interest: -281342.00
MDM.V income_statement (quarterly, 2026-02-28) — Net Income From Continuing Operation Net Minority Interest: -86841.00
MDM.V cash_flow (annual, 2026-02-28) — Net Income From Continuing Operations: -281342.00
MDM.V cash_flow (quarterly, 2026-02-28) — Net Income From Continuing Operations: -86841.00
MDM.V income_statement (annual, 2026-02-28) — Net Income Including Noncontrolling Interests: -281342.00
MDM.V income_statement (quarterly, 2026-02-28) — Net Income Including Noncontrolling Interests: -86841.00
MDM.V income_statement (annual, 2026-02-28) — Net Interest Income: 28253.00
MDM.V income_statement (quarterly, 2026-02-28) — Net Interest Income: 5605.00
MDM.V income_statement (annual, 2026-02-28) — Net Non Operating Interest Income Expense: 28253.00
MDM.V income_statement (quarterly, 2026-02-28) — Net Non Operating Interest Income Expense: 5605.00
MDM.V cash_flow (annual, 2026-02-28) — Net Other Investing Changes: -148909.00
MDM.V cash_flow (quarterly, 2026-02-28) — Net Other Investing Changes: -110119.00
MDM.V balance_sheet (annual, 2026-02-28) — Net PPE: 593094.00
MDM.V balance_sheet (quarterly, 2026-02-28) — Net PPE: 593094.00
MDM.V cash_flow (annual, 2026-02-28) — Net PPE Purchase And Sale: 0.00
MDM.V balance_sheet (annual, 2026-02-28) — Net Tangible Assets: 1640422.00
MDM.V balance_sheet (quarterly, 2026-02-28) — Net Tangible Assets: 1640422.00
MDM.V income_statement (annual, 2026-02-28) — Normalized EBITDA: -506297.00
MDM.V income_statement (quarterly, 2026-02-28) — Normalized EBITDA: -195604.00
MDM.V income_statement (annual, 2026-02-28) — Normalized Income: -379693.00
MDM.V income_statement (quarterly, 2026-02-28) — Normalized Income: -138420.00
MDM.V cash_flow (annual, 2026-02-28) — Operating Cash Flow: -353856.00
MDM.V cash_flow (quarterly, 2026-02-28) — Operating Cash Flow: -127437.00
MDM.V income_statement (annual, 2026-02-28) — Operating Income: -407946.00
MDM.V income_statement (quarterly, 2026-02-28) — Operating Income: -144025.00
MDM.V income_statement (annual, 2026-02-28) — Operating Revenue: 0.00
MDM.V income_statement (quarterly, 2026-02-28) — Operating Revenue: 0.00
MDM.V balance_sheet (annual, 2026-02-28) — Ordinary Shares Number: 93146716.00
MDM.V balance_sheet (quarterly, 2026-02-28) — Ordinary Shares Number: 93146716.00
MDM.V balance_sheet (annual, 2026-02-28) — Other Equity Interest: 52573.00
MDM.V balance_sheet (quarterly, 2026-02-28) — Other Equity Interest: 52573.00
MDM.V income_statement (annual, 2026-02-28) — Other Gand A: 264792.00
MDM.V income_statement (quarterly, 2026-02-28) — Other Gand A: 111289.00
MDM.V income_statement (annual, 2026-02-28) — Other Income Expense: 98351.00
MDM.V income_statement (quarterly, 2026-02-28) — Other Income Expense: 51579.00
MDM.V income_statement (annual, 2026-02-28) — Other Operating Expenses: 99569.00
MDM.V income_statement (quarterly, 2026-02-28) — Other Operating Expenses: 21985.00
MDM.V balance_sheet (annual, 2026-02-28) — Other Short Term Investments: 142775.00
MDM.V balance_sheet (quarterly, 2026-02-28) — Other Short Term Investments: 142775.00
MDM.V balance_sheet (annual, 2026-02-28) — Payables: 61462.00
MDM.V balance_sheet (quarterly, 2026-02-28) — Payables: 61462.00
MDM.V balance_sheet (annual, 2026-02-28) — Payables And Accrued Expenses: 144064.00
MDM.V balance_sheet (quarterly, 2026-02-28) — Payables And Accrued Expenses: 144064.00
MDM.V balance_sheet (annual, 2026-02-28) — Prepaid Assets: 5143.00
MDM.V balance_sheet (quarterly, 2026-02-28) — Prepaid Assets: 5143.00
MDM.V income_statement (annual, 2026-02-28) — Pretax Income: -281342.00
MDM.V income_statement (quarterly, 2026-02-28) — Pretax Income: -86841.00
MDM.V balance_sheet (annual, 2026-02-28) — Receivables: 30576.00
MDM.V balance_sheet (quarterly, 2026-02-28) — Receivables: 30576.00
MDM.V income_statement (annual, 2026-02-28) — Rent And Landing Fees: 12000.00
MDM.V income_statement (quarterly, 2026-02-28) — Rent And Landing Fees: 3000.00
MDM.V income_statement (annual, 2026-02-28) — Rent Expense Supplemental: 12000.00
MDM.V income_statement (quarterly, 2026-02-28) — Rent Expense Supplemental: 3000.00
MDM.V balance_sheet (annual, 2026-02-28) — Retained Earnings: -7627032.00
MDM.V balance_sheet (quarterly, 2026-02-28) — Retained Earnings: -7627032.00
MDM.V income_statement (annual, 2026-02-28) — Salaries And Wages: 24000.00
MDM.V income_statement (quarterly, 2026-02-28) — Salaries And Wages: 6000.00
MDM.V cash_flow (annual, 2026-02-28) — Sale Of PPE: 0.00
MDM.V income_statement (annual, 2026-02-28) — Selling General And Administration: 308377.00
MDM.V income_statement (quarterly, 2026-02-28) — Selling General And Administration: 122040.00
MDM.V balance_sheet (annual, 2026-02-28) — Share Issued: 93146716.00
MDM.V balance_sheet (quarterly, 2026-02-28) — Share Issued: 93146716.00
MDM.V income_statement (annual, 2026-02-28) — Special Income Charges: -1200.00
MDM.V income_statement (quarterly, 2026-02-28) — Special Income Charges: -237.00
MDM.V balance_sheet (annual, 2026-02-28) — Stockholders Equity: 1640422.00
MDM.V balance_sheet (quarterly, 2026-02-28) — Stockholders Equity: 1640422.00
MDM.V balance_sheet (annual, 2026-02-28) — Tangible Book Value: 1640422.00
MDM.V balance_sheet (quarterly, 2026-02-28) — Tangible Book Value: 1640422.00
MDM.V income_statement (annual, 2026-02-28) — Tax Effect Of Unusual Items: 0.00
MDM.V income_statement (quarterly, 2026-02-28) — Tax Effect Of Unusual Items: 0.00
MDM.V income_statement (annual, 2026-02-28) — Tax Rate For Calcs: 0.00
MDM.V income_statement (quarterly, 2026-02-28) — Tax Rate For Calcs: 0.00
MDM.V balance_sheet (annual, 2026-02-28) — Taxes Receivable: 29144.00
MDM.V balance_sheet (quarterly, 2026-02-28) — Taxes Receivable: 29144.00
MDM.V balance_sheet (annual, 2026-02-28) — Total Assets: 1784486.00
MDM.V balance_sheet (quarterly, 2026-02-28) — Total Assets: 1784486.00
MDM.V balance_sheet (annual, 2026-02-28) — Total Capitalization: 1640422.00
MDM.V balance_sheet (quarterly, 2026-02-28) — Total Capitalization: 1640422.00
MDM.V balance_sheet (annual, 2026-02-28) — Total Equity Gross Minority Interest: 1640422.00
MDM.V balance_sheet (quarterly, 2026-02-28) — Total Equity Gross Minority Interest: 1640422.00
MDM.V income_statement (annual, 2026-02-28) — Total Expenses: 407946.00
MDM.V income_statement (quarterly, 2026-02-28) — Total Expenses: 144025.00
MDM.V balance_sheet (annual, 2026-02-28) — Total Liabilities Net Minority Interest: 144064.00
MDM.V balance_sheet (quarterly, 2026-02-28) — Total Liabilities Net Minority Interest: 144064.00
MDM.V balance_sheet (annual, 2026-02-28) — Total Non Current Assets: 593094.00
MDM.V balance_sheet (quarterly, 2026-02-28) — Total Non Current Assets: 593094.00
MDM.V balance_sheet (annual, 2026-02-28) — Total Non Current Liabilities Net Minority Interest: 0.00
MDM.V balance_sheet (quarterly, 2026-02-28) — Total Non Current Liabilities Net Minority Interest: 0.00
MDM.V income_statement (annual, 2026-02-28) — Total Unusual Items: 98351.00
MDM.V income_statement (quarterly, 2026-02-28) — Total Unusual Items: 51579.00
MDM.V income_statement (annual, 2026-02-28) — Total Unusual Items Excluding Goodwill: 98351.00
MDM.V income_statement (quarterly, 2026-02-28) — Total Unusual Items Excluding Goodwill: 51579.00
MDM.V cash_flow (annual, 2026-02-28) — Unrealized Gain Loss On Investment Securities: -97625.00
MDM.V cash_flow (quarterly, 2026-02-28) — Unrealized Gain Loss On Investment Securities: -50650.00
MDM.V balance_sheet (annual, 2026-02-28) — Working Capital: 1047328.00
MDM.V balance_sheet (quarterly, 2026-02-28) — Working Capital: 1047328.00
MDM.V income_statement (annual, 2026-02-28) — Write Off: 1200.00
MDM.V income_statement (quarterly, 2026-02-28) — Write Off: 237.00
MDNA.TO income_statement (annual, 2022-03-31) — +Operating Expense: 22473000.00
MDNA.TO income_statement (annual, 2022-03-31) — +Total Revenue: 0.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Accounts Payable: 1672000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 7926000.00
MDNA.TO income_statement (annual, 2022-03-31) — Basic Average Shares: 54286671.00
MDNA.TO income_statement (annual, 2022-03-31) — Basic EPS: -0.42
MDNA.TO cash_flow (annual, 2022-03-31) — Beginning Cash Position: 30375000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Capital Lease Obligations: 0.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Capital Stock: 83671000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 20535000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 20535000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Cash Equivalents: 5000000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Cash Financial: 15535000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Cash Flow From Continuing Financing Activities: 3878000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Cash Flow From Continuing Investing Activities: 10050000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Cash Flow From Continuing Operating Activities: -23584000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Change In Payables And Accrued Expense: -1452000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Change In Receivables: -392000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Change In Working Capital: -1844000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Changes In Cash: -9656000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Common Stock: 83671000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Common Stock Equity: 20835000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Common Stock Issuance: 3509000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Current Accrued Expenses: 949000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Current Assets: 23391000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Current Capital Lease Obligation: 0.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Current Liabilities: 2621000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Depreciation: 38000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Depreciation Amortization Depletion: 38000.00
MDNA.TO income_statement (annual, 2022-03-31) — Depreciation Amortization Depletion Income Statement: 37000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 38000.00
MDNA.TO income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 37000.00
MDNA.TO income_statement (annual, 2022-03-31) — Depreciation Income Statement: 37000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Derivative Product Liabilities: 0.00
MDNA.TO income_statement (annual, 2022-03-31) — Diluted Average Shares: 54286671.00
MDNA.TO income_statement (annual, 2022-03-31) — Diluted EPS: -0.42
MDNA.TO income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: -22577000.00
MDNA.TO income_statement (annual, 2022-03-31) — EBIT: -22473000.00
MDNA.TO income_statement (annual, 2022-03-31) — EBITDA: -22435000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Effect Of Exchange Rate Changes: -184000.00
MDNA.TO cash_flow (annual, 2022-03-31) — End Cash Position: 20535000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Financing Cash Flow: 3878000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Free Cash Flow: -23584000.00
MDNA.TO income_statement (annual, 2022-03-31) — Gain On Sale Of Security: -173000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Gains Losses Not Affecting Retained Earnings: 171000.00
MDNA.TO income_statement (annual, 2022-03-31) — General And Administrative Expense: 7720000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 65000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Gross PPE: 0.00
MDNA.TO income_statement (annual, 2022-03-31) — Interest Income: 69000.00
MDNA.TO income_statement (annual, 2022-03-31) — Interest Income Non Operating: 69000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Invested Capital: 20835000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Investing Cash Flow: 10050000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 3509000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Long Term Debt Payments: -37000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: 3509000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Net Foreign Currency Exchange Gain Loss: 121000.00
MDNA.TO income_statement (annual, 2022-03-31) — Net Income: -22577000.00
MDNA.TO income_statement (annual, 2022-03-31) — Net Income Common Stockholders: -22577000.00
MDNA.TO income_statement (annual, 2022-03-31) — Net Income Continuous Operations: -22577000.00
MDNA.TO income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: -22577000.00
MDNA.TO income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: -22577000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: -22577000.00
MDNA.TO income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: -22577000.00
MDNA.TO income_statement (annual, 2022-03-31) — Net Interest Income: 69000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Net Investment Purchase And Sale: 10050000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: -37000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: -37000.00
MDNA.TO income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: 69000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Net PPE: 0.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 20770000.00
MDNA.TO income_statement (annual, 2022-03-31) — Normalized EBITDA: -22262000.00
MDNA.TO income_statement (annual, 2022-03-31) — Normalized Income: -22404000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Operating Cash Flow: -23584000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Operating Gains Losses: 121000.00
MDNA.TO income_statement (annual, 2022-03-31) — Operating Income: -22473000.00
MDNA.TO income_statement (annual, 2022-03-31) — Operating Revenue: 0.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 55647479.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Other Equity Adjustments: 171000.00
MDNA.TO income_statement (annual, 2022-03-31) — Other Gand A: 5808000.00
MDNA.TO income_statement (annual, 2022-03-31) — Other Income Expense: -173000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Other Non Cash Items: -737000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Other Short Term Investments: 0.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Payables: 1672000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Payables And Accrued Expenses: 2621000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Prepaid Assets: 1548000.00
MDNA.TO income_statement (annual, 2022-03-31) — Pretax Income: -22577000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Proceeds From Stock Option Exercised: 406000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Purchase Of Investment: -10000000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Receivables: 1308000.00
MDNA.TO income_statement (annual, 2022-03-31) — Reconciled Depreciation: 38000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Repayment Of Debt: -37000.00
MDNA.TO income_statement (annual, 2022-03-31) — Research And Development: 14716000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Retained Earnings: -70933000.00
MDNA.TO income_statement (annual, 2022-03-31) — Salaries And Wages: 1912000.00
MDNA.TO cash_flow (annual, 2022-03-31) — Sale Of Investment: 20050000.00
MDNA.TO income_statement (annual, 2022-03-31) — Selling General And Administration: 7720000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Share Issued: 55647479.00
MDNA.TO cash_flow (annual, 2022-03-31) — Stock Based Compensation: 1415000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Stockholders Equity: 20835000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Tangible Book Value: 20770000.00
MDNA.TO income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 0.00
MDNA.TO income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Taxes Receivable: 1308000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Total Assets: 23456000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Total Capitalization: 20835000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Total Debt: 0.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 20835000.00
MDNA.TO income_statement (annual, 2022-03-31) — Total Expenses: 22473000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 2621000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 65000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
MDNA.TO income_statement (annual, 2022-03-31) — Total Unusual Items: -173000.00
MDNA.TO income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: -173000.00
MDNA.TO balance_sheet (annual, 2022-03-31) — Working Capital: 20770000.00
MDNA.TO income_statement (annual, 2023-03-31) — +Operating Expense: 16303000.00
MDNA.TO income_statement (annual, 2023-03-31) — +Total Revenue: 0.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Accounts Payable: 1617000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 9486000.00
MDNA.TO income_statement (annual, 2023-03-31) — Basic Average Shares: 64736493.00
MDNA.TO income_statement (annual, 2023-03-31) — Basic EPS: -0.16
MDNA.TO cash_flow (annual, 2023-03-31) — Beginning Cash Position: 20535000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Capital Stock: 100924000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 33596000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 33596000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Cash Equivalents: 32800000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Cash Financial: 796000.00
MDNA.TO cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Financing Activities: 24760000.00
MDNA.TO cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Investing Activities: 0.00
MDNA.TO cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Operating Activities: -12657000.00
MDNA.TO cash_flow (annual, 2023-03-31) — Change In Payables And Accrued Expense: 1179000.00
MDNA.TO cash_flow (annual, 2023-03-31) — Change In Receivables: 1231000.00
MDNA.TO cash_flow (annual, 2023-03-31) — Change In Working Capital: 2410000.00
MDNA.TO cash_flow (annual, 2023-03-31) — Changes In Cash: 12103000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Common Stock: 100924000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Common Stock Equity: 29486000.00
MDNA.TO cash_flow (annual, 2023-03-31) — Common Stock Issuance: 24760000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Current Accrued Expenses: 2183000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Current Assets: 36385000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Current Liabilities: 3800000.00
MDNA.TO cash_flow (annual, 2023-03-31) — Depreciation: 4000.00
MDNA.TO cash_flow (annual, 2023-03-31) — Depreciation Amortization Depletion: 4000.00
MDNA.TO income_statement (annual, 2023-03-31) — Depreciation Amortization Depletion Income Statement: 5000.00
MDNA.TO cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 4000.00
MDNA.TO income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 5000.00
MDNA.TO income_statement (annual, 2023-03-31) — Depreciation Income Statement: 5000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Derivative Product Liabilities: 3160000.00
MDNA.TO income_statement (annual, 2023-03-31) — Diluted Average Shares: 64736493.00
MDNA.TO income_statement (annual, 2023-03-31) — Diluted EPS: -0.16
MDNA.TO income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: -10048000.00
MDNA.TO income_statement (annual, 2023-03-31) — EBIT: -16303000.00
MDNA.TO income_statement (annual, 2023-03-31) — EBITDA: -16298000.00
MDNA.TO cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 958000.00
MDNA.TO cash_flow (annual, 2023-03-31) — End Cash Position: 33596000.00
MDNA.TO cash_flow (annual, 2023-03-31) — Financing Cash Flow: 24760000.00
MDNA.TO cash_flow (annual, 2023-03-31) — Free Cash Flow: -12657000.00
MDNA.TO cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -4158000.00
MDNA.TO income_statement (annual, 2023-03-31) — Gain On Sale Of Security: 5341000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Gains Losses Not Affecting Retained Earnings: 57000.00
MDNA.TO income_statement (annual, 2023-03-31) — General And Administrative Expense: 6994000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 61000.00
MDNA.TO income_statement (annual, 2023-03-31) — Interest Income: 914000.00
MDNA.TO income_statement (annual, 2023-03-31) — Interest Income Non Operating: 914000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Invested Capital: 29486000.00
MDNA.TO cash_flow (annual, 2023-03-31) — Investing Cash Flow: 0.00
MDNA.TO cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 24760000.00
MDNA.TO cash_flow (annual, 2023-03-31) — Long Term Debt Payments: 0.00
MDNA.TO cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 24760000.00
MDNA.TO cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: -1072000.00
MDNA.TO income_statement (annual, 2023-03-31) — Net Income: -10048000.00
MDNA.TO income_statement (annual, 2023-03-31) — Net Income Common Stockholders: -10048000.00
MDNA.TO income_statement (annual, 2023-03-31) — Net Income Continuous Operations: -10048000.00
MDNA.TO income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: -10048000.00
MDNA.TO income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: -10048000.00
MDNA.TO cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: -10048000.00
MDNA.TO income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: -10048000.00
MDNA.TO income_statement (annual, 2023-03-31) — Net Interest Income: 914000.00
MDNA.TO cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 0.00
MDNA.TO cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 0.00
MDNA.TO cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 0.00
MDNA.TO income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 914000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 29425000.00
MDNA.TO income_statement (annual, 2023-03-31) — Normalized EBITDA: -21639000.00
MDNA.TO income_statement (annual, 2023-03-31) — Normalized Income: -15389000.00
MDNA.TO cash_flow (annual, 2023-03-31) — Operating Cash Flow: -12657000.00
MDNA.TO cash_flow (annual, 2023-03-31) — Operating Gains Losses: -5230000.00
MDNA.TO income_statement (annual, 2023-03-31) — Operating Income: -16303000.00
MDNA.TO income_statement (annual, 2023-03-31) — Operating Revenue: 0.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 69637469.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Other Equity Adjustments: 57000.00
MDNA.TO income_statement (annual, 2023-03-31) — Other Gand A: 5185000.00
MDNA.TO income_statement (annual, 2023-03-31) — Other Income Expense: 5341000.00
MDNA.TO cash_flow (annual, 2023-03-31) — Other Non Cash Items: -1164000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Payables: 1617000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Payables And Accrued Expenses: 3800000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Prepaid Assets: 1934000.00
MDNA.TO income_statement (annual, 2023-03-31) — Pretax Income: -10048000.00
MDNA.TO cash_flow (annual, 2023-03-31) — Proceeds From Stock Option Exercised: 0.00
MDNA.TO cash_flow (annual, 2023-03-31) — Purchase Of Investment: 0.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Receivables: 855000.00
MDNA.TO income_statement (annual, 2023-03-31) — Reconciled Depreciation: 4000.00
MDNA.TO cash_flow (annual, 2023-03-31) — Repayment Of Debt: 0.00
MDNA.TO income_statement (annual, 2023-03-31) — Research And Development: 9304000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Retained Earnings: -80981000.00
MDNA.TO income_statement (annual, 2023-03-31) — Salaries And Wages: 1809000.00
MDNA.TO cash_flow (annual, 2023-03-31) — Sale Of Investment: 0.00
MDNA.TO income_statement (annual, 2023-03-31) — Selling General And Administration: 6994000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Share Issued: 69637469.00
MDNA.TO cash_flow (annual, 2023-03-31) — Stock Based Compensation: 1371000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Stockholders Equity: 29486000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Tangible Book Value: 29425000.00
MDNA.TO income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 0.00
MDNA.TO income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Taxes Receivable: 855000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Total Assets: 36446000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Total Capitalization: 29486000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 29486000.00
MDNA.TO income_statement (annual, 2023-03-31) — Total Expenses: 16303000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 6960000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 61000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 3160000.00
MDNA.TO income_statement (annual, 2023-03-31) — Total Unusual Items: 5341000.00
MDNA.TO income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 5341000.00
MDNA.TO balance_sheet (annual, 2023-03-31) — Working Capital: 32585000.00
MDNA.TO income_statement (annual, 2024-03-31) — +Operating Expense: 18674000.00
MDNA.TO income_statement (annual, 2024-03-31) — +Total Revenue: 0.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Accounts Payable: 2070000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 10695000.00
MDNA.TO income_statement (annual, 2024-03-31) — Basic Average Shares: 69637469.00
MDNA.TO income_statement (annual, 2024-03-31) — Basic EPS: -0.37
MDNA.TO cash_flow (annual, 2024-03-31) — Beginning Cash Position: 33596000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 0.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 0.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Capital Stock: 100924000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 16982000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 16982000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Cash Equivalents: 11200000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Cash Financial: 5782000.00
MDNA.TO cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Financing Activities: 0.00
MDNA.TO cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Investing Activities: 0.00
MDNA.TO cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Operating Activities: -16260000.00
MDNA.TO cash_flow (annual, 2024-03-31) — Change In Payables And Accrued Expense: -937000.00
MDNA.TO cash_flow (annual, 2024-03-31) — Change In Receivables: 1678000.00
MDNA.TO cash_flow (annual, 2024-03-31) — Change In Working Capital: 741000.00
MDNA.TO cash_flow (annual, 2024-03-31) — Changes In Cash: -16260000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Common Stock: 100924000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Common Stock Equity: 5191000.00
MDNA.TO cash_flow (annual, 2024-03-31) — Common Stock Issuance: 0.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Current Accrued Expenses: 793000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Current Assets: 19077000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 0.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Current Liabilities: 2863000.00
MDNA.TO cash_flow (annual, 2024-03-31) — Depreciation: 4000.00
MDNA.TO cash_flow (annual, 2024-03-31) — Depreciation Amortization Depletion: 4000.00
MDNA.TO income_statement (annual, 2024-03-31) — Depreciation Amortization Depletion Income Statement: 5000.00
MDNA.TO cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 4000.00
MDNA.TO income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 5000.00
MDNA.TO income_statement (annual, 2024-03-31) — Depreciation Income Statement: 5000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Derivative Product Liabilities: 11080000.00
MDNA.TO income_statement (annual, 2024-03-31) — Diluted Average Shares: 69637469.00
MDNA.TO income_statement (annual, 2024-03-31) — Diluted EPS: -0.37
MDNA.TO income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: -25466000.00
MDNA.TO income_statement (annual, 2024-03-31) — EBIT: -18674000.00
MDNA.TO income_statement (annual, 2024-03-31) — EBITDA: -18669000.00
MDNA.TO cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: -354000.00
MDNA.TO cash_flow (annual, 2024-03-31) — End Cash Position: 16982000.00
MDNA.TO cash_flow (annual, 2024-03-31) — Financing Cash Flow: 0.00
MDNA.TO cash_flow (annual, 2024-03-31) — Free Cash Flow: -16260000.00
MDNA.TO cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: 7920000.00
MDNA.TO income_statement (annual, 2024-03-31) — Gain On Sale Of Security: -7990000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Gains Losses Not Affecting Retained Earnings: 19000.00
MDNA.TO income_statement (annual, 2024-03-31) — General And Administrative Expense: 7869000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 57000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Gross PPE: 0.00
MDNA.TO income_statement (annual, 2024-03-31) — Interest Income: 1198000.00
MDNA.TO income_statement (annual, 2024-03-31) — Interest Income Non Operating: 1198000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Invested Capital: 5191000.00
MDNA.TO cash_flow (annual, 2024-03-31) — Investing Cash Flow: 0.00
MDNA.TO cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 0.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 0.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 0.00
MDNA.TO cash_flow (annual, 2024-03-31) — Long Term Debt Payments: 0.00
MDNA.TO cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 0.00
MDNA.TO cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: 316000.00
MDNA.TO income_statement (annual, 2024-03-31) — Net Income: -25466000.00
MDNA.TO income_statement (annual, 2024-03-31) — Net Income Common Stockholders: -25466000.00
MDNA.TO income_statement (annual, 2024-03-31) — Net Income Continuous Operations: -25466000.00
MDNA.TO income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: -25466000.00
MDNA.TO income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: -25466000.00
MDNA.TO cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: -25466000.00
MDNA.TO income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: -25466000.00
MDNA.TO income_statement (annual, 2024-03-31) — Net Interest Income: 1198000.00
MDNA.TO cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 0.00
MDNA.TO cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 0.00
MDNA.TO income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: 1198000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Net PPE: 0.00
MDNA.TO cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: 0.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 5134000.00
MDNA.TO income_statement (annual, 2024-03-31) — Normalized EBITDA: -10679000.00
MDNA.TO income_statement (annual, 2024-03-31) — Normalized Income: -17476000.00
MDNA.TO cash_flow (annual, 2024-03-31) — Operating Cash Flow: -16260000.00
MDNA.TO cash_flow (annual, 2024-03-31) — Operating Gains Losses: 8236000.00
MDNA.TO income_statement (annual, 2024-03-31) — Operating Income: -18674000.00
MDNA.TO income_statement (annual, 2024-03-31) — Operating Revenue: 0.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 69637469.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Other Equity Adjustments: 19000.00
MDNA.TO income_statement (annual, 2024-03-31) — Other Gand A: 5522000.00
MDNA.TO income_statement (annual, 2024-03-31) — Other Income Expense: -7990000.00
MDNA.TO cash_flow (annual, 2024-03-31) — Other Non Cash Items: -984000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Payables: 2070000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Payables And Accrued Expenses: 2863000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Prepaid Assets: 931000.00
MDNA.TO income_statement (annual, 2024-03-31) — Pretax Income: -25466000.00
MDNA.TO cash_flow (annual, 2024-03-31) — Proceeds From Stock Option Exercised: 0.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Properties: 0.00
MDNA.TO cash_flow (annual, 2024-03-31) — Purchase Of PPE: 0.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Receivables: 1164000.00
MDNA.TO income_statement (annual, 2024-03-31) — Reconciled Depreciation: 4000.00
MDNA.TO cash_flow (annual, 2024-03-31) — Repayment Of Debt: 0.00
MDNA.TO income_statement (annual, 2024-03-31) — Research And Development: 10800000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Retained Earnings: -106447000.00
MDNA.TO income_statement (annual, 2024-03-31) — Salaries And Wages: 2347000.00
MDNA.TO income_statement (annual, 2024-03-31) — Selling General And Administration: 7869000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Share Issued: 69637469.00
MDNA.TO cash_flow (annual, 2024-03-31) — Stock Based Compensation: 1209000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Stockholders Equity: 5191000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Tangible Book Value: 5134000.00
MDNA.TO income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 0.00
MDNA.TO income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Taxes Receivable: 1164000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Total Assets: 19134000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Total Capitalization: 5191000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Total Debt: 0.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 5191000.00
MDNA.TO income_statement (annual, 2024-03-31) — Total Expenses: 18674000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 13943000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 57000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 11080000.00
MDNA.TO income_statement (annual, 2024-03-31) — Total Unusual Items: -7990000.00
MDNA.TO income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -7990000.00
MDNA.TO balance_sheet (annual, 2024-03-31) — Working Capital: 16214000.00
MDNA.TO income_statement (quarterly, 2024-09-30) — Basic Average Shares: 76837596.00
MDNA.TO income_statement (quarterly, 2024-09-30) — Basic EPS: -0.05
MDNA.TO cash_flow (quarterly, 2024-09-30) — Capital Expenditure: -2000.00
MDNA.TO income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 76837596.00
MDNA.TO income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.05
MDNA.TO cash_flow (quarterly, 2024-09-30) — Long Term Debt Payments: 0.00
MDNA.TO cash_flow (quarterly, 2024-09-30) — Net Issuance Payments Of Debt: 0.00
MDNA.TO cash_flow (quarterly, 2024-09-30) — Net Long Term Debt Issuance: 0.00
MDNA.TO balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 9831000.00
MDNA.TO cash_flow (quarterly, 2024-09-30) — Purchase Of PPE: -2000.00
MDNA.TO cash_flow (quarterly, 2024-09-30) — Repayment Of Debt: 0.00
MDNA.TO income_statement (quarterly, 2024-12-31) — +Operating Expense: 5120000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — +Total Revenue: 0.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 1880000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 10720000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Basic Average Shares: 78009084.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Basic EPS: -0.07
MDNA.TO cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 30426000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 154000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 174000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Capital Stock: 116297000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 29996000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 29996000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Cash Equivalents: 27473000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Cash Financial: 2523000.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: 1908000.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: 0.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Operating Activities: -3555000.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: 300000.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Change In Receivables: 240000.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Change In Working Capital: 540000.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Changes In Cash: -1647000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Common Stock: 116297000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 17451000.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 1254000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Current Assets: 32011000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 40000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 40000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 3174000.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Depreciation: 18000.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 18000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 21000.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 18000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 21000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 21000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 11480000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 78009084.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Diluted EPS: -0.07
MDNA.TO income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: -5191000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — EBIT: -5120000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — EBITDA: -5099000.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Effect Of Exchange Rate Changes: 1217000.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — End Cash Position: 29996000.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: 1908000.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Free Cash Flow: -3555000.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: 1613000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: -449000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 42000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 1507000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 53000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Gross PPE: 175000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Interest Income: 378000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 378000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Invested Capital: 17451000.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: 0.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 134000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 134000.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: 0.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -1164000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Net Income: -5191000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: -5191000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: -5191000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -5191000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -5191000.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: -5191000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: -5191000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Net Interest Income: 378000.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: 0.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: 378000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Net PPE: 175000.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: 0.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 17398000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Normalized EBITDA: -4650000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Normalized Income: -4742000.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: -3555000.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: 449000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Operating Income: -5120000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Operating Revenue: 0.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 78215735.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: 42000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Other Equity Interest: 9831000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Other Gand A: 687000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Other Income Expense: -449000.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: 0.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Other Properties: 21000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Payables: 1880000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 3134000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 588000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Pretax Income: -5191000.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 1908000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: 0.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Receivables: 1427000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 18000.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: 0.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Research And Development: 3592000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -119439000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Salaries And Wages: 820000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Selling General And Administration: 1507000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Share Issued: 78215735.00
MDNA.TO cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: 629000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 17451000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 17398000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 1427000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Total Assets: 32239000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 17451000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Total Debt: 174000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 17451000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Total Expenses: 5120000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 14788000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 228000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 11614000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Total Unusual Items: -449000.00
MDNA.TO income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -449000.00
MDNA.TO balance_sheet (quarterly, 2024-12-31) — Working Capital: 28837000.00
MDNA.TO income_statement (annual, 2025-03-31) — +Operating Expense: 20406000.00
MDNA.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 5719000.00
MDNA.TO income_statement (annual, 2025-03-31) — +Total Revenue: 0.00
MDNA.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Accounts Payable: 2701000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 2701000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 11216000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 11216000.00
MDNA.TO income_statement (annual, 2025-03-31) — Basic Average Shares: 76671175.00
MDNA.TO income_statement (annual, 2025-03-31) — Basic EPS: -0.15
MDNA.TO cash_flow (annual, 2025-03-31) — Beginning Cash Position: 16982000.00
MDNA.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 29996000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 141000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 141000.00
MDNA.TO cash_flow (annual, 2025-03-31) — Capital Expenditure: -33000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 168000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 168000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Capital Stock: 116297000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 116297000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 24837000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 24837000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 24837000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 24837000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Cash Equivalents: 23559000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 23559000.00
MDNA.TO balance_sheet (annual, 2025-03-31) — Cash Financial: 1278000.00
MDNA.TO balance_sheet (quarterly, 2025-03-31) — Cash Financial: 1278000.00
MDNA.TO cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Financing Activities: 23492000.00
MDNA.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -19000.00